New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Anti-obesity medications may affect survival in people with knee or hip osteoarthritis

Anti-obesity medications may affect survival in people with knee or hip osteoarthritis

byWileyCredit: Pixabay/CC0 Public DomainNew researchpublishedinArthritis & Rheumatologysuggests that for people overweight or with obesity who also have knee or hip o
Breakthroughs January 26,2024
Anti-obesity medications may affect survival in people with knee or hip osteoarthritis

Anti-obesity medications may affect survival in people with knee or hip osteoarthritis

byWileyCredit: Pixabay/CC0 Public DomainNew researchpublishedinArthritis & Rheumatologysuggests that for people overweight or with obesity who also have knee or hip o
Breakthroughs January 26,2024
Study offers new insights into how immune cells recognize their enemies

Study offers new insights into how immune cells recognize their enemies

by Gunnar Bartsch,Julius-Maximilians-Universität WürzburgPAg induced Vγ9Vδ2 T cell activation by BTN3A-BTN2A1 composite ligand. Credit:Nature Communications(2023). DOI: 10.1038/s4146
Immunology & Rheumatology January 26,2024
Study offers new insights into how immune cells recognize their enemies

Study offers new insights into how immune cells recognize their enemies

by Gunnar Bartsch,Julius-Maximilians-Universität WürzburgPAg induced Vγ9Vδ2 T cell activation by BTN3A-BTN2A1 composite ligand. Credit:Nature Communications(2023). DOI: 10.1038/s4146
Immunology & Rheumatology January 26,2024
New study finds diabetes drug may reduce risk for colorectal cancer

New study finds diabetes drug may reduce risk for colorectal cancer

byCase Western Reserve UniversityCredit: CC0 Public DomainA study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce
Breakthroughs January 26,2024
New study finds diabetes drug may reduce risk for colorectal cancer

New study finds diabetes drug may reduce risk for colorectal cancer

byCase Western Reserve UniversityCredit: CC0 Public DomainA study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce
Breakthroughs January 26,2024
Scientists solve 18-year-old mystery and find the once-elusive source of a critical T cell population

Scientists solve 18-year-old mystery and find the once-elusive source of a critical T cell population

by Delthia Ricks , Medical XpressPresence of Tcf7+CD8+T cells during the primary response to infection. (A) Experimental schematic: Naïve P14 cells (CD45.2) were transferred into congenica
Immunology & Rheumatology January 26,2024
Scientists solve 18-year-old mystery and find the once-elusive source of a critical T cell population

Scientists solve 18-year-old mystery and find the once-elusive source of a critical T cell population

by Delthia Ricks , Medical XpressPresence of Tcf7+CD8+T cells during the primary response to infection. (A) Experimental schematic: Naïve P14 cells (CD45.2) were transferred into congenica
Immunology & Rheumatology January 26,2024
HIV: Thwarting a protein in the hope of a better quality of life

HIV: Thwarting a protein in the hope of a better quality of life

by Bruno Geoffroy, University of Montreal Hospital Research Centre (CRCHUM)Credit: Pixabay/CC0 Public DomainTo mark the occasion of World AIDS Day, Dr. Madeleine Durand and Andrés Finzi are working to
Dermatology January 26,2024
HIV: Thwarting a protein in the hope of a better quality of life

HIV: Thwarting a protein in the hope of a better quality of life

by Bruno Geoffroy, University of Montreal Hospital Research Centre (CRCHUM)Credit: Pixabay/CC0 Public DomainTo mark the occasion of World AIDS Day, Dr. Madeleine Durand and Andrés Finzi are working to
Dermatology January 26,2024
Clinical trial shows efficacy for atezolizumab combined with carboplatin

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati
Oncology January 26,2024
Clinical trial shows efficacy for atezolizumab combined with carboplatin

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati
Oncology January 26,2024
Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030
Oncology January 26,2024
Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030
Oncology January 26,2024
How the immune system fights to keep herpes at bay

How the immune system fights to keep herpes at bay

by Jake Miller,Harvard Medical SchoolThese microscope images show how interferon in the nucleus raises levels of the protective protein IFI16 (stained green) from low background levels (left) to
Public Health & Prevention January 26,2024
How the immune system fights to keep herpes at bay

How the immune system fights to keep herpes at bay

by Jake Miller,Harvard Medical SchoolThese microscope images show how interferon in the nucleus raises levels of the protective protein IFI16 (stained green) from low background levels (left) to
Public Health & Prevention January 26,2024
Minimizing immunotherapy's potentially harmful side effects

Minimizing immunotherapy's potentially harmful side effects

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainRecent advances in treating multiple myeloma, the second most common blood cancer, and other blood mali
Oncology January 25,2024
Minimizing immunotherapy's potentially harmful side effects

Minimizing immunotherapy's potentially harmful side effects

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainRecent advances in treating multiple myeloma, the second most common blood cancer, and other blood mali
Oncology January 25,2024
This gross mixture has big benefits for the study of bacteria

This gross mixture has big benefits for the study of bacteria

byUniversity of MichiganDetermining the bottleneck of infection forP. mirabilisduring UTI. (A–C) CBA/J mice were transurethrally inoculated with 107CFU. The inoculum contained
Immunology & Rheumatology January 25,2024
This gross mixture has big benefits for the study of bacteria

This gross mixture has big benefits for the study of bacteria

byUniversity of MichiganDetermining the bottleneck of infection forP. mirabilisduring UTI. (A–C) CBA/J mice were transurethrally inoculated with 107CFU. The inoculum contained
Immunology & Rheumatology January 25,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com